Kffhealthnews
Published October 15, 2026
GLP-1 Drugs Cut Psychiatric Hospital Admissions For Schizophrenia By 24%: Study
Read the full story at Kffhealthnews
Compass Pathways CEO: Psychedelics Company Will 'Go Slow Before We Go Fast' ... psychedelic therapy for regulatory review this quarter, will “go.
Surfaced by this Google Alert
- Psychedelics